{ "company_number": "09600771", "name": "Cambridge Molecular Diagnostics Ltd", "url": "/company/09600771", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2015-05-20", "dissolved_on": null, "sic_codes": [ { "code": "72110", "description": "Research and experimental development on biotechnology", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/72110" } ], "registered_address": { "id": 1034887, "url": "/address/1034887", "line1": "25 SCIENCE PARK, BIO-INNOVATION CENTRE", "line2": "MILTON ROAD", "post_town": "CAMBRIDGE", "county": "", "country": "ENGLAND", "postcode": "CB4 0FW" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09600771", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-09-30", "last_made_up": "2025-12-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/09600771/accounts/2025-12-31", "pdf_url": "/company/09600771/accounts/2025-12-31.pdf", "made_up_date": "2025-12-31", "period_start": "2025-01-01", "period_end": "2025-12-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "2854824.00", "debtors": "167346.00", "cash_bank_in_hand": "9822.00", "current_assets": "177168.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-360140.00", "total_assets_less_current_liabilities": "2494684.00", "net_assets_liabilities": "2494684.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "6383.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-171709.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2026.zip" }, { "url": "/company/09600771/accounts/2024-12-31", "pdf_url": "/company/09600771/accounts/2024-12-31.pdf", "made_up_date": "2024-12-31", "period_start": "2024-02-01", "period_end": "2024-12-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "2399611.00", "debtors": "210007.00", "cash_bank_in_hand": "39977.00", "current_assets": "252773.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-104847.00", "total_assets_less_current_liabilities": "2294764.00", "net_assets_liabilities": "2294764.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1169.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": "2789.00", "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-145689.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2025.zip" }, { "url": "/company/09600771/accounts/2024-01-31", "pdf_url": "/company/09600771/accounts/2024-01-31.pdf", "made_up_date": "2024-01-31", "period_start": "2023-02-01", "period_end": "2024-01-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "1751058.00", "debtors": "174965.00", "cash_bank_in_hand": "418851.00", "current_assets": "596605.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "552637.00", "total_assets_less_current_liabilities": "2303695.00", "net_assets_liabilities": "2303695.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "978.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": "2789.00", "staff_costs": "24116.00", "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-302254.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2024.zip" }, { "url": "/company/09600771/accounts/2023-01-31", "pdf_url": "/company/09600771/accounts/2023-01-31.pdf", "made_up_date": "2023-01-31", "period_start": "2022-04-01", "period_end": "2023-01-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "1282413.00", "debtors": "180818.00", "cash_bank_in_hand": "176595.00", "current_assets": "358952.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-426775.00", "total_assets_less_current_liabilities": "855638.00", "net_assets_liabilities": "855638.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "637.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": "1539.00", "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-240808.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2023.zip" }, { "url": "/company/09600771/accounts/2022-03-31", "pdf_url": "/company/09600771/accounts/2022-03-31.pdf", "made_up_date": "2022-03-31", "period_start": "2021-06-01", "period_end": "2022-03-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "5.00", "tangible_fixed_assets": "935830.00", "debtors": "123020.00", "cash_bank_in_hand": "172566.00", "current_assets": "295586.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "241635.00", "total_assets_less_current_liabilities": "1177465.00", "net_assets_liabilities": "497465.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "541.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-119010.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2022.zip" }, { "url": "/company/09600771/accounts/2021-05-31", "pdf_url": "/company/09600771/accounts/2021-05-31.pdf", "made_up_date": "2021-05-31", "period_start": "2020-06-01", "period_end": "2021-05-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "712481.00", "debtors": "108946.00", "cash_bank_in_hand": "451304.00", "current_assets": "560250.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "543994.00", "total_assets_less_current_liabilities": "1256475.00", "net_assets_liabilities": "616475.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "541.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-111649.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2021.zip" }, { "url": "/company/09600771/accounts/2020-05-31", "pdf_url": "/company/09600771/accounts/2020-05-31.pdf", "made_up_date": "2020-05-31", "period_start": "2020-05-31", "period_end": "2020-05-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "368759.00", "debtors": "106515.00", "cash_bank_in_hand": "110858.00", "current_assets": "217373.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "210501.00", "total_assets_less_current_liabilities": "579260.00", "net_assets_liabilities": "579260.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "511.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2021.zip" }, { "url": "/company/09600771/accounts/2019-05-31", "pdf_url": "/company/09600771/accounts/2019-05-31.pdf", "made_up_date": "2019-05-31", "period_start": "2019-05-31", "period_end": "2019-05-31", "entity_name": "Cambridge Molecular Diagnostics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "161277.00", "debtors": "50850.00", "cash_bank_in_hand": "403633.00", "current_assets": "454483.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "423848.00", "total_assets_less_current_liabilities": "585125.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "511.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2020.zip" }, { "url": "/company/09600771/accounts/2018-05-31", "pdf_url": "/company/09600771/accounts/2018-05-31.pdf", "made_up_date": "2018-05-31", "period_start": "2018-05-31", "period_end": "2018-05-31", "entity_name": "Cambridge Molecular Diagnostics Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "47408.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "19345.00", "creditors_due_within_one_year": "33856.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-14511.00", "total_assets_less_current_liabilities": "32897.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "31823.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2019.zip" }, { "url": "/company/09600771/accounts/2017-05-31", "pdf_url": "/company/09600771/accounts/2017-05-31.pdf", "made_up_date": "2017-05-31", "period_start": "2017-05-31", "period_end": "2017-05-31", "entity_name": "Cambridge Molecular Diagnostics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "29276.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "43742.00", "creditors_due_within_one_year": "33.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "43709.00", "total_assets_less_current_liabilities": "72985.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "39011.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2018.zip" }, { "url": "/company/09600771/accounts/2016-05-31", "pdf_url": "/company/09600771/accounts/2016-05-31.pdf", "made_up_date": "2016-05-31", "period_start": "2016-05-31", "period_end": "2016-05-31", "entity_name": "Cambridge Molecular Diagnostics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "5521.00", "debtors": null, "cash_bank_in_hand": "17773.00", "current_assets": null, "creditors_due_within_one_year": "1707.00", "creditors_due_after_one_year": "32900.00", "net_current_assets_liabilities": "16066.00", "total_assets_less_current_liabilities": "21587.00", "net_assets_liabilities": "-11313.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-11413.00", "shareholder_funds": "-11313.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2017.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09600771/filing-history" }, "confirmation_statement": { "next_due": "2027-03-03", "last_made_up": "2026-02-17" }, "officers": [], "psc": [ { "name": "Cotterford Company Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent", "voting-rights-50-to-75-percent" ], "notified_on": "2026-05-01", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Mr Gustavo Cerda Moya", "kind": "individual-person-with-significant-control", "person_url": "/person/1795330", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "Chilean", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:50:00.959197+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }